Sen. Frist's Diagnosis On DTC: GAO Report, Two-Year Moratorium For New Drugs

Majority Leader Frist requests Government Accountability Office examine FDA's oversight of direct-to-consumer ads and their impact on drug usage and costs. The senator also requests drug companies voluntarily restrict DTC ads during the first two years a product is on the market.